Quarterly ResultMay 15, 2026, 04:08 PM
United Health Products Q1 Net Loss $(315,842); Going Concern Doubt
AI Summary
United Health Products reported a net loss of $(315,842) for Q1 2026, a significant improvement from $(1,531,659) in Q1 2025, primarily due to reduced operating expenses. However, the company continues to face substantial doubt about its ability to continue as a going concern, citing recurring net losses, negative working capital, and insufficient revenue to cover operating expenses. Cash and cash equivalents declined sharply to $1,029 by March 31, 2026, from $65,249 at the end of 2025, further highlighting its precarious financial position.
Key Highlights
- Net loss for Q1 2026 was $(315,842), significantly lower than $(1,531,659) in Q1 2025.
- Revenues remained $0 for both the three months ended March 31, 2026, and March 31, 2025.
- Cash and cash equivalents decreased to $1,029 at March 31, 2026, from $65,249 at Dec 31, 2025.
- Total current assets fell to $47,200 at March 31, 2026, from $105,392 at Dec 31, 2025.
- Total current liabilities increased to $4,191,118 at March 31, 2026, from $3,943,149 at Dec 31, 2025.
- Stockholders' Deficit worsened to $(4,192,293) at March 31, 2026, from $(3,876,451) at Dec 31, 2025.
- Selling, general and administrative expenses decreased to $253,019 in Q1 2026 from $1,372,965 in Q1 2025.
- Research and development expenses decreased to $12,562 in Q1 2026 from $116,251 in Q1 2025.
Price Impact
More from UEEC